Sign Up
Stories
Curia Elevates Biologics Leadership
Share
Acelyrin Appoints Ken Lock as Chief Comm...
Agile Leadership Training for Pharma Pro...
Berkem's Financial Outlook: 2023 & Beyon...
Afya Limited Expands Medical Seats in Br...
BMY Expands Portfolio with RayzeBio Acqu...
BioCatch Valued at $1.3B
Overview
API
Curia appoints Steve Lavezoli as VP of Biologics to bolster life science mission.
Ask a question
How might Lavezoli's background influence the strategic direction of Curia's biologics division?
In what ways could this appointment impact the competitiveness of Curia within the CDMO industry?
What specific advancements or changes could Lavezoli implement to enhance Curia's biologics capabilities?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage